65
Participants
Start Date
February 6, 2019
Primary Completion Date
March 11, 2020
Study Completion Date
May 5, 2020
MSTT1041A
Participants will receive subcutaneous (SC) MSTT1041A
Placebo
Participants will receive SC placebo
Florida Pulmonary Research Institute, LLC, Winter Park
South Coast Research Center, Inc., Miami
Harmony Clinical Research, Inc, North Miami Beach
Forward Clinical Trials, Tampa
GCP Global Clinical Professionals, St. Petersburg
Alabama Allergy & Asthma, Birmingham
Dermatology Specialists Research, LLC, Louisville
Universitatsklinikum Munster, Münster
Midwest Sinus Allergy and Asthma - CRN, Normal
Vital Prospects Clinical Research Institute PC - CRN, Tulsa
Center for Clinical Studies, Houston
Asthma & Allergy; Associates, P.C., Colorado Springs
Clinical Research Consortium Nevada, Las Vegas
California Allergy and Asthma Medical Group - CRN, Los Angeles
Jonathan Corren MD, Inc., Los Angeles
Skin Laser and Surgery Specialists of New York and New Jersey LLC - Interspond - PPDS, Hackensack
Centrum Medyczne ALL-MED, Krakow
SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi, Lodz
Kliniczny Szpital Wojewodzki Nr 1 im. Fryderyka Chopina; Klinika Dermatologii, Rzeszów
Laser Clinic, Szczecin
Wro Medica, Wroc?aw
Lead Sponsor
Genentech, Inc.
INDUSTRY